Biomedical literature, made navigable
Discover articles through diseases, drugs, treatments, interventions, clinical instruments, institutions and funders extracted from the BMJ open corpus.
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentionsChoose an entity to see the articles in which it was identified.
…Introduction Diffuse cutaneous systemic sclerosis (dcSSc) is a lethal rheumatic disease that is characterized by progress…
… by recombinant S100A4, and significantly attenuated in SScF by AX-202.Material and Methods Gene set enrichment analysis interrogated …
…11), Centre Hospitalier Universitaire de Lyon (France, n = 11), Nippon Medical School (Japan, n = 5) and University Medical Centre Ljubljana (Sloveni…
…urgitation. Exposure to immunosuppressive agents (methotrexate, mycophenolate mofetil, azathioprine, cyclophosphamide, tacrolimus, leflunomide, ritux…
…ostadil in 2013 and iloprost in 2016, both initially effective. Iloprost was successfully re-administered in 2019 and 2024 but discontin…
…wound-care services and the use of the recommended intervention sharp debridement.Material and Methods An online survey was conducted during June…
…Introduction Synovitis is a common manifestation of systemic sclerosis (SSc), driving …
…trials were randomized, and just one used an active comparator (rituximab). Mostly early diffuse cutaneous SSc (dcSSc) were eligible for …
…illed out questionnaires assessing global function (Scleroderma Health Assessment Questionnaire, SHAQ), quality of life (Medical outcomes study Short Form 36, …
…ncluding ESI and sham procedures. Data sources included PubMed, Cochrane Central, Embase, and Web of Science up to December 31, 2024. Inclusion …
…Background HCV transmission among MSM is associated with high-risk behaviours …